Celularity Inc (CELU)
2.76
-0.09
(-3.16%)
USD |
NASDAQ |
Nov 22, 16:00
2.77
+0.01
(+0.36%)
After-Hours: 20:00
Celularity Debt to Equity Ratio: 1.474 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.474 |
| March 31, 2024 | 1.274 |
| December 31, 2023 | 0.958 |
| September 30, 2023 | 1.157 |
| June 30, 2023 | 0.2856 |
| March 31, 2023 | 0.2293 |
| December 31, 2022 | 0.1891 |
| September 30, 2022 | 0.239 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.0137 |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2020
1.474
Maximum
Jun 2024
0.4157
Average
0.2092
Median
Debt to Equity Ratio Benchmarks
| Eli Lilly and Co | 2.185 |
| Dentsply Sirona Inc | 0.89 |
| Ligand Pharmaceuticals Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 135.49M |
| Total Liabilities (Quarterly) | 107.68M |
| Shareholders Equity (Quarterly) | 27.81M |
| Current Ratio | 0.2611 |
| Net Debt Paydown Yield | -1.55% |